Related Experiment Videos

Matrix metalloproteinases in tumour invasion and metastasis

S Curran1, G I Murray

  • 1Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, U.K.

The Journal of Pathology
|November 5, 1999
PubMed

Insights

Matrix metalloproteinases (MMPs) degrade the extracellular matrix, aiding tumor invasion and metastasis. Inhibiting MMPs offers a promising therapeutic strategy for various cancers.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are a diverse group of enzymes crucial for extracellular matrix degradation.
  • MMPs are categorized into subgroups like collagenases, gelatinases, and stromelysins based on substrate specificity.
  • Emerging evidence highlights the significant involvement of specific MMPs in tumor invasion and metastasis.

Purpose of the Study:

  • To review the multifaceted roles of MMPs in tumor invasion and metastasis.
  • To emphasize the clinical relevance of MMP involvement in cancer progression.
  • To discuss the therapeutic potential of MMP inhibition in cancer treatment.

Main Methods:

  • Literature review focusing on studies with clinical relevance.
  • Analysis of existing research on MMP classification and function.
  • Examination of the impact of MMPs on the tumor microenvironment.

Main Results:

  • MMPs facilitate tumor invasion directly through extracellular matrix degradation.
  • MMPs play a critical role in shaping the tumor microenvironment, promoting tumor growth.
  • Several broad-spectrum MMP inhibitors are under clinical evaluation for cancer therapy.

Conclusions:

  • MMPs are key players in tumor invasion and metastasis.
  • Targeting MMPs represents a viable therapeutic avenue for cancer treatment.
  • Further clinical studies are essential to validate the efficacy of MMP inhibitors.

Related Concept Videos